TU Delft and UMC Utrecht spinout MILabs has been purchased by Rigaku Corporation, which plans to use its medical imaging technology in drug development.

Scientific instrument producer Rigaku Corporation has paid an undisclosed amount to acquire MILabs, a Netherlands-based medical scanning system developer spun out of University Medical Center Utrecht and TU Delft. MILabs has created a multimodal system that incorporates X-ray computed tomography (CT), positron emission tomography (PET), single-photon emission computed tomography (SPECT) and optical imaging capabilities. Frederik…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.